Market Access News | pharmaphorum

News

A digital therapy to reduce the severity of chronic tic disorders like Tourette syndrome has been recommended for use by the NHS for the first time.

News

AstraZeneca has its first regulatory approval for an inhaler product using a propellant with a massively reduced global warming potential.

News

President Donald Trump said he will sign an order today to cut prescription drug prices in the US to the level paid by other comparable countries.

News

Hopes that the UK-US trade agreement would give some clarity on the situation for pharmaceuticals proved optimistic.

News

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US.

News

President Trump is rumoured to be resurrecting a policy that would see drug prices offered to federal programmes tied to those offered overseas.